|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Female Reproductive Tract |
Department of Obstetrics and Gynecology,3 Indiana University School of Medicine, Indianapolis, Indiana 46202-5121
Medical Sciences Program,4 Indiana University, Bloomington, Indiana 47405
Department of Biochemistry,5 University of Missouri, Columbia, Missouri 65211
Estrogen induces proliferation of uterine epithelium through a paracrine action of estrogen receptor (ER
) in the underlying stroma. In ovariectomized mice primed with progesterone, estrogen stimulates proliferation in both the epithelium and the stroma. We set out to test whether a paracrine mode of action is involved in estrogen-induced proliferation of the uterine stroma. Epithelial and mesenchymal tissues derived from uteri of neonatal ER
null mice (ER
KO) or wild-type mice were separated and recombined in all four possible configurations (ER
+ or ER
- epithelium with ER
+ or ER
- mesenchyme) and grafted into female athymic mice. After 5 wk, hosts were ovariectomized and challenged with hormone treatment, and cellular proliferation was monitored by thymidine autoradiography. Results showed that, although the full response of the epithelium was dependent on an ER
-positive mesenchyme, stromal cell proliferation was independent of tissue ER
. This latter observation suggests that the response of the stroma was due to a systemic factor induced in the ER
-positive hosts. To test this possibility, pieces of whole uterus from neonatal wild-type or ER
KO mice were grafted into syngeneic wild-type or ER
KO hosts. In these whole-uterus grafts, estradiol stimulated ER
KO uterine stroma when they were grown in wild-type hosts but not when grown in ER
KO hosts. The epithelium of whole-uterus ER
KO grafts did not respond to estrogen, regardless of the host phenotype. These observations suggest that treatment of progesterone-primed mice with estradiol stimulates production of a systemic factor that is capable of inducing uterine stromal cell proliferation and that this systemic factor is produced by an ER
-dependent mechanism.
2 Correspondence: Robert M. Bigsby, Department of Obstetrics and Gynecology, Indiana University School of Medicine, 975 West Walnut St. (IB360), Indianapolis, IN 46202-5121. FAX: 317 278 2884; rbigsby{at}iupui.edu
This article has been cited by other articles:
![]() |
Y. Liang, C. Besch-Williford, R. A. Brekken, and S. M. Hyder Progestin-Dependent Progression of Human Breast Tumor Xenografts: A Novel Model for Evaluating Antitumor Therapeutics Cancer Res., October 15, 2007; 67(20): 9929 - 9936. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. K. Marriott, K. R. McGann-Gramling, B. Hauss-Wegrzyniak, L. C. Sheldahl, R. A. Shapiro, D. M. Dorsa, and G. L. Wenk Brain Infusion of Lipopolysaccharide Increases Uterine Growth as a Function of Estrogen Replacement Regimen: Suppression of Uterine Estrogen Receptor-{alpha} by Constant, But Not Pulsed, Estrogen Replacement Endocrinology, January 1, 2007; 148(1): 232 - 240. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |